Biotech ETFs Lead Q3 Rally: XBI Breaks Out
September 22, 2016 at 21:00 PM EDT
The biotech sector is doing much better since BREXIT in late June despite a sell-off in late August. We are still trying to escape a bear market mentality because of the Q1 correction and concerns about drug prices.